Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Top Device Research Payments: PARTNER II, Cardio, Neuro, Dx Device Trials Highest In 2014

This article was originally published in The Pink Sheet Daily

Executive Summary

The transcatheter aortic valve PARTNER II study, several stent trials, and studies looking at diagnostic tools and neurological devices dominated the top ten trials by total payment to clinical investigators in 2014, according to an analysis of CMS' Open Payments database.


Related Content

FDA Plans Acute Stroke Device Workshop; Guidance Could Follow
Longer Anti-Platelet Therapy Reduces Thrombosis Risks With Drug-Eluting Stents
Research In Brief


Related Companies